# Osmol Therapeutics, Inc. — Form D

Osmol Therapeutics, Inc. of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-28. The offering totals $7.5M, of which $2.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-02-28
- Form: D
- Accession: 0001694244-22-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $7.5M
- Amount sold: $2.3M
- Remaining: $5.2M
- Investors: 4
- Date of first sale: 2022-02-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-435142

## Issuer

- Name: Osmol Therapeutics, Inc.
- CIK: 0001694244
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 33 WHITNEY AVENUE, NEW HAVEN, CT, 06510
- Phone: 617-719-9406

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Robert Berman | Director | New York, NY |
| Vlad Coric | Director | Baltimore, MD |
| Michael Ehrlich | Director | New Haven, CT |
| Robert Linke | Director | New Haven, CT |
| Robert Linke | Executive Officer | New Haven, CT |
| Brian Dixon | Director | Orlando, FL |
| Brian Dixon | Executive Officer | Orlando, FL |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-01-18](https://search.stillhousedata.com/formd/0001694244-17-000001) | D | $3.0M | $550K |

## More

- [CIK 1694244 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1694244&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001694244-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.